Immunome, Inc., a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced the appointment of Phil Roberts as Chief Technical Officer....
NiKang Therapeutics Inc., a clinical stage biotech company focused on developing innovative small molecule oncology medicines to help patients with unmet medical needs, announced...
MaxCyte, Inc, a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative...
Frontage Laboratories, Inc., announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism &...
Synlogic, Inc., a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, announced that it has entered...
